REVIVE INJURY AND WELLNESS

Serial Number 97754801
641

Registration Progress

Application Filed
Jan 14, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

REVIVE INJURY AND WELLNESS

Basic Information

Serial Number
97754801
Filing Date
January 14, 2023
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
641
Status Date
Oct 13, 2023
Application
Pending
Classes
044

Rights Holder

Greene, Ellen

01
Address
4718 East Betty Elyse Lane
Phoenix, AZ 85032

Ownership History

Greene, Ellen

Original Applicant
01
Phoenix, AZ

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

6 events
Date Code Type Description Documents
Oct 13, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 13, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 13, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Oct 11, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 4, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 18, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Medical services, namely, platelet-rich plasma injections, intravenous therapy for delivering nutrients and hydration into the bloodstream, dermal facial fillers, botulinum toxin injections, diagnostic testing, namely, electromyography (EMG), Vestibular Autorotation Testing (VAT), and Electronystagmogram (ENG), initial injury evaluation, pain management evaluation, and neurology consultations; Intravenous (IV) hydration therapy services; Intravenous (IV) vitamin therapy services; Medical testing for diagnostic or treatment purposes; Physical therapy evaluation, identification, and management of movement dysfunction to restore, maintain, and promote optimal physical function preventing the onset, symptoms and progression of impairments, functional limitations, and disabilities resulting from disease, disorders, conditions, or injuries; Skin treatment, namely, the injection of dermal fillers to reduce the appearance of facial fine lines; Skin treatments, namely, the injection of dermal filling agents and neuromuscular blocking agents to reduce the appearance of facial lines and wrinkles
First Use Anywhere: Aug 15, 2022
First Use in Commerce: Aug 15, 2022

Classification

International Classes
044